About VISIE
VISIE is a Healthcare company based in Austin (United States) founded in 2017 by Aaron Bernstein and Patrick Edwards. VISIE has raised $12.71 million across 9 funding rounds from investors including Epilepsy Foundation, Capital Factory and Medingenii. Its chief executive, as recorded, is Douglas Fairbanks Fairbanks. VISIE offers products and services including 3D Spatial Computing Platform and 3D Scanners. Its focus areas include Life Sciences, Surgical Instruments, Intraoperative Blood Salvage and Neurology. Its legal entity is VISIE INC. Its competitors include Caresyntax, Haemonetics and ClearPoint Neuro; 2 of its 3 listed competitors have raised funding.
Company details
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery. The companys proprietary maging hardware combines the power of science and deep tech to develop intraoperative scanners to streamline surgeries in the operating room.
- Headquarters Austin, United States
- Founders Aaron Bernstein, Patrick Edwards
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website visievision.com
- Social LinkedIn
- Legal Name Visie Inc.
- Total Equity Funding$12.71M (USD)
in 9 rounds
- Latest Funding Round$2.97M (USD), Series A
Apr 2025
- InvestorsEpilepsy Foundation
& 8 more
Products & Services of VISIE
VISIE offers a comprehensive portfolio of products and services, including 3D Spatial Computing Platform and 3D Scanners.
Platform for 3D vision to enhance surgical accuracy and navigation.
Investigational tools for precise anatomical tracking in surgery.
Funding Insights of VISIE
VISIE has successfully raised a total of $12.71M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2.97 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.71M
- Total Rounds 9
- Last Round Series A — $2.97M
- First Round $25,000
(Jan 2018)
- Investors Count 9
All 9 funding rounds of VISIE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $2.97M | Series A | – | – | – |
| Nov 2023 | $8.2M | Series A | – | – | – |
| Feb 2021 | Series A | – | Capital Factory | – | |
| Aug 2020 | Series A | – | Medingenii | – | |
| Mar 2019 | $1.54M | Angel Round | – | Flat Rock Global | |
| Mar 2018 | $20,000 | Grant | – | – | |
| Feb 2018 | Grant | – | – | ||
| Feb 2018 | $150,000 | Grant | – | – | |
| Jan 2018 | $25,000 | Grant | – | – |
9 investors in total: 8 institutional and 1 angel.
Investors in VISIE
VISIE has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Epilepsy Foundation, Capital Factory and Medingenii.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Acceleration is provided to seed-stage, early-stage, and later-stage companies. | capitalfactory.com | Austin, United States | ||
Medingenii is engaged in investing in healthcare innovation companies. | 2019 | medingenii.com | Houston, United States | |
Cartmell Ventures is focused on early-stage health IT investments. | 2021 | cartmellventures.com | ||
Flat Rock Global is recognized as an alternative credit manager. | 2016 | flatrockglobal.com | Jackson, USA | |
Early-stage entrepreneurs are accelerated through MassChallenge's program. | masschallenge.org | Boston, United States | ||
Community health and wellness are advanced in Temple, Texas. | templebioscience.org | Temple, United States | ||
A competition for new ventures is hosted by Texas A&M. | texasnvc.org | United States | ||
Epilepsy research and treatment are supported by foundation funding. | 1967 | epilepsyfoundation.org | Greater Landover, United States | |
EC Emma Cartmell | Angel investor and advisor, ex-CEO of MYOB, focused on tech startups | unknown_514de648a5394bce8 |
Investor details for VISIE
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VISIE
3 people are tracked at VISIE (3 in leadership).
| Name | Role | Group |
|---|---|---|
Aaron Bernstein | Co-Founder & CTO | Leadership |
Patrick Edwards | Co-Founder | Leadership |
Douglas Fairbanks Fairbanks | CEO | Leadership |
Complete people profiles for VISIE
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VISIE
3 dated milestones of VISIE across 8 years, from founding to its latest funding, stage changes and deals.
- Founded VISIE is founded.
- Funding First funding round of $25K.
- Funding Latest funding round, Series A, of $3.0M.
Competitors of VISIE
VISIE has 3 listed competitors in our database, 2 of them funded. They include Caresyntax, Haemonetics and ClearPoint Neuro.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| caresyntax.com | 2013 | Boston, United States | $302.5M | 64 | Surgical outcomes are enhanced via analytics and integration platform. | |
| haemonetics.com | 1971 | Braintree, United States | 3,034 | Hematology products and solutions are provided for medical applications. | ||
| clearpointneuro.com | 1998 | Irvine, United States | $17.04M | 38 | Software and hardware solutions for MRI-guided surgical planning are provided. |
Detailed competitors of VISIE
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VISIE
The website of VISIE (visievision.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▼ 5.9% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as VISIE (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Visie
Complete news archive for VISIE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VISIE
VISIE was founded in 2017 and raised its 1st funding round 1 year after it was founded.
VISIE is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Douglas Fairbanks Fairbanks is the CEO of VISIE, as recorded in our data.
VISIE is a funded company, having raised a total of $12.71M across 9 funding rounds to date. The company's 1st funding round was a Grant of $25K, raised on Jan 2018.
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery. The companys proprietary maging hardware combines the power of science and deep tech to develop intraoperative scanners to streamline surgeries in the operating room.
VISIE's top competitors include Caresyntax, ClearPoint Neuro and Haemonetics.
VISIE offers 3D Spatial Computing Platform and 3D Scanners.
VISIE has 9 investors. Key investors include Epilepsy Foundation, Capital Factory, Medingenii, Cartmell Ventures, and Flat Rock Global.
VISIE operates through Visie Inc..